Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Equillium, Inc.EQ · Entity 6560 | Chief Development Officer | January 02, 2024 | January 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Equillium, Inc.
Report date January 02, 2024 · Filed January 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,150 |
Ending reported balance
After 2023-12-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-06-09 · Grant · Acquired 15,000 · Balance 49,346 F1: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 2 · 2023-12-08 · Grant · Acquired 8,804 · Balance 58,150 F1: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.73 · Expires 2034-01-01 | Direct | 175,000 |
Reported balance
After 2024-01-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-01-02 · Grant · Acquired 175,000 · Balance 175,000 F2: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2024 Filed Jan 3, 2024 23:14 UTC | Equillium, Inc. EQ · Entity 6560 | GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-24-000518 · doc4.xml · derivative · entry 3 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-01-01 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| December 08, 2023 Filed Jan 3, 2024 23:14 UTC | Equillium, Inc. EQ · Entity 6560 | GrantCommon Stock | 8,804 | $0.58 | $5,106.32 |
DisclosureSEC source: 0001209191-24-000518 · doc4.xml · nonDerivative · entry 2 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,150 F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 09, 2023 Filed Jan 3, 2024 23:14 UTC | Equillium, Inc. EQ · Entity 6560 | GrantCommon Stock | 15,000 | $0.56 | $8,400.00 |
DisclosureSEC source: 0001209191-24-000518 · doc4.xml · nonDerivative · entry 1 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,346 F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 23:48 UTC | Equillium, Inc. EQ · Entity 6560 | GrantEmployee Stock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001209191-23-001366 · doc4.xml · derivative · entry 3 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2033-01-02 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| December 09, 2022 Filed Jan 4, 2023 23:48 UTC | Equillium, Inc. EQ · Entity 6560 | GrantCommon Stock | 3,821 | $1.19 | $4,546.99 |
DisclosureSEC source: 0001209191-23-001366 · doc4.xml · nonDerivative · entry 2 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,346 F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 10, 2022 Filed Jan 4, 2023 23:48 UTC | Equillium, Inc. EQ · Entity 6560 | GrantCommon Stock | 6,244 | $1.85 | $11,551.40 |
DisclosureSEC source: 0001209191-23-001366 · doc4.xml · nonDerivative · entry 1 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,525 F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 19, 2022 Filed Feb 7, 2023 23:42 UTC | Equillium, Inc. EQ · Entity 6560 | GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001209191-23-007677 · doc4.xml · derivative · entry 1 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-01-18 F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 14:58 UTC | Equillium, Inc. EQ · Entity 6560 | GrantCommon Stock | 1,290 | $2.35 | $3,031.50 |
DisclosureSEC source: 0001209191-21-069176 · doc4.xml · nonDerivative · entry 1 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,281 F1 · kind: The shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:55 UTC | Equillium, Inc. EQ · Entity 6560 | GrantCommon stock, par value $0.0001 per share | 7,742 | $2.35 | $18,193.70 |
DisclosureSEC source: 0001209191-21-040313 · doc4.xml · nonDerivative · entry 1 Rothman Joel · CIK 0001842921 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,991 F1 · kind: The shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.